GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Earkart Ltd

Earkart Ltd H1 FY27 Investor Presentation Highlights Hearing Care Gap

RESULTS ● No Immediate Change MEDIUM RISK
📅 Filed on BSE: 21 Nov 2026, 08:18 PM IST  ·  BSE ID: eca2d1ff-b476-4c78-b85e-493f05a6d034
View Original BSE Filing (PDF)
💡
In Simple Terms
Earkart Ltd released an investor presentation detailing the market opportunity in hearing care and its strategy for H1 FY27.
🤖 AI Summary
  • Earkart Ltd submitted an Investor Presentation for the unaudited financial results for H1 FY27.
  • The presentation emphasizes a global hearing loss burden affecting 430 million people needing rehabilitation today.
  • India's hearing care gap is highlighted with only 1 audiologist per 2 lakh people and 6%-26.9% estimated population affected.
  • Earkart's strategy includes 105 Shop-in-Shop clinics in 55+ cities and OMNI 2.0 for remote audiology services.
  • Key H1 FY27 financials: Revenue from operations of ₹3107.00 lakhs, EBITDA ₹183.35 lakhs, PAT ₹71.77 lakhs.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (H1 FY27)
₹3107.00 lakhs
EBITDA (H1 FY27)
₹183.35 lakhs
PAT (H1 FY27)
₹71.77 lakhs
EBITDA margin (H1 FY27)
5.90%
PAT margin (H1 FY27)
2.30%
ROE (H1 FY27)
1.11%
ROCE (H1 FY27)
1.90%
🏢 How This Affects the Company
📈
Business Impact
Earkart's presentation reinforces its focus on addressing the hearing care gap in India through its OMNI 2.0 remote audiology platform and expanding Shop-in-Shop clinic network (105 clinics live). The company manufactures its own hearing aid brands (EQFY, Fame, Radius, Tiny) and ENT pharmaceutical formulations, aiming to provide affordable and accessible care.
💰
Financial Impact
For H1 FY27, the company reported Revenue from operations of ₹3107.00 lakhs, EBITDA of ₹183.35 lakhs, and PAT of ₹71.77 lakhs. These figures establish baseline performance for the first half of the current fiscal year.
⚙️
Operational Impact
The OMNI 2.0 remote audiology system enables one audiologist to remotely serve 4–7 clinics, increasing reach without needing more onsite specialists. The Shop-in-Shop model leverages existing ENT footfall, adding revenue per patient.
⚠️
Risk Impact
The presentation identifies the 'Care Gap' and 'India's Gap is Widest' as market challenges, which Earkart aims to address. The structural shortage of audiologists could be a long-term operational constraint if the company's remote audiology model does not scale effectively.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this investor presentation.
👤
Who Is Affected
All shareholders are affected as the presentation provides an overview of the company's market strategy, operational approach, and H1 FY27 financial performance, including Revenue from operations of ₹3107.00 lakhs.
🔍
Management Signal
Management signals its focus on addressing the substantial hearing care gap in India through a scalable model combining remote audiology technology and physical clinic expansion.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — review revenue and profit growth trends.
Updates on Shop-in-Shop clinic network expansion targets for FY27.
Details on OMNI 2.0 system deployment across new locations.
MEDIUM RISK The company operates in a sector with significant access gaps and competition, requiring effective scaling.
💡 Investor Takeaway
Earkart Ltd's H1 FY27 investor presentation details a market with 430 million people globally needing rehabilitation and India's significant audiologist shortage. The company's strategy involves 105 Shop-in-Shop clinics and OMNI 2.0 remote audiology. Key financials for H1 FY27 include Revenue from operations of ₹3107.00 lakhs and PAT of ₹71.77 lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Earkart operates 105 Shop-in-Shop clinics across 55+ cities, demonstrating broad physical market penetration.
  • The OMNI 2.0 remote audiology platform, with an Indian patent granted in 2025, allows one audiologist to serve 4–7 clinics remotely.

⚠️ Concerns

  • The presentation highlights a significant 'Care Gap' where over 400 million people could benefit from hearing devices, but less than 20% need is met.
  • India faces a structural shortage of audiologists, with only 1 audiologist per 2 lakh people, posing an access challenge.
📅 Company Track Record
Earkart Ltd recently reported Q2 FY27 PAT fell 37.04% to Rs. 116.68 Lakh, despite a 38.68% revenue growth. The company scheduled an earnings call for its Q2 FY27 financial results on November 26, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What were Earkart Ltd's key financial figures for H1 FY27?
Earkart Ltd reported Revenue from operations of ₹3107.00 lakhs, EBITDA of ₹183.35 lakhs, and PAT of ₹71.77 lakhs for H1 FY27.
What is Earkart Ltd's strategy to address India's hearing care gap?
Earkart's strategy includes operating 105 Shop-in-Shop clinics across 55+ cities and deploying OMNI 2.0, a patented remote audiology platform.
What is the market need for hearing devices as per the presentation?
Over 400 million people globally could benefit from a hearing device, but less than 20% of that need is currently met.
What is the audiologist-to-population ratio in India mentioned in the presentation?
India has a ratio of 1 audiologist per 2 lakh people, highlighting a structural shortage in hearing care access.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses free when you sign up

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel